Frontlight ResearchEarly access
What researchers published on Psoriatic arthritis
768 papers, newest first.
Showing 80 of 768
ReviewHarmonising difficult-to-manage and complex-to-manage psoriatic arthritis: from divergent prevalence estimates to reproducible, mechanism-aware phenotypes.The Lancet. Rheumatology
Measuring treatment response in psoriatic arthritis: comparison between PSoriatic Arthritis Response Criteria and Disease Activity Score.Rheumatology advances in practice
ReviewEfficacy and safety of deucravacitinib versus placebo in active psoriatic arthritis: a systematic review and meta-analysis.Autoimmunity reviews
Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial.Arthritis & rheumatology (Hoboken, N.J.)
Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.Rheumatology and therapy
Observational studyUnderstanding barriers: patient experience with immune-mediated rheumatic diseases in Brazilian public health.Advances in rheumatology (London, England)
ReviewMultidomain efficacy and safety of IL-17A and IL-17A/F inhibitors versus adalimumab in biologic-naïve psoriatic arthritis: A systematic review and Meta-analysis of comparative trials.Autoimmunity reviews
Foot and ankle involvement is common across the spondyloarthritis spectrum with distinct anatomical and clinical patterns: a post hoc cross-sectional analysis of the ASAS-PerSpA study.Rheumatology international
Extracapsular and joint-dominant hand and wrist MRI patterns in psoriatic and rheumatoid arthritis: an exploratory case-control study.Frontiers in immunology
Impact of radiographic damage on health-related outcomes across rheumatoid arthritis, psoriatic arthritis, and hand osteoarthritis: a comparative analysis of disease burden.Clinical rheumatology
Implementing Psoriatic Arthritis Screening and Dietary Interventions in Dermatology Practice: A Prospective Clinical Study.Journal of drugs in dermatology : JDD
Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors.Journal of drugs in dermatology : JDD
Bimekizumab in Psoriatic Arthritis: 12-Month Retention, Multidomain Effectiveness, and Impact of Prior Interleukin-17 Inhibition in a Real-World Cohort.Joint bone spine
Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Case reportAdult-onset chronic nonbacterial osteitis mimicking refractory axial psoriatic arthritis: successful treatment with combined IL-1/IL-17 inhibition: a case report and brief literature review.EULAR rheumatology open
Case reportPsoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.Cureus
Response to correspondence on 'Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials' by Annfeldt et al.Annals of the rheumatic diseases
Difficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry.Seminars in arthritis and rheumatism
The development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET).Arthritis & rheumatology (Hoboken, N.J.)
Incidence and prevalence of hidradenitis suppurativa across spondyloarthritis-related diseases: cohort study using electronic health records.Frontiers in immunology
Real‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial.Annals of the rheumatic diseases
Simplified liquid chromatography-mass spectrometry quantification of adalimumab reveals peptide interference and modestly stronger exposure-response associations than ELISA.Analytica chimica acta
Predictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA).Rheumatology (Oxford, England)
Meta-analysisEpidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence.Diabetes/metabolism research and reviews
In plain wordsRead moreRead the paper on PubMedImmunogenicity, Safety, and Clinical Outcomes Following Homologous and Heterologous SARS-CoV-2 Vaccination Regimens in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Prospective Observational Study from the SAFER Cohort.Vaccines
Lightweight interpretable support vector machine SERS (LiSVM-SERS) learning framework for serological diagnosis of psoriatic arthritis and biomarker identification.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Systematic reviewExercise, physical activity, and physical fitness in psoriasis and psoriatic arthritis: an umbrella review.Frontiers in immunology
In plain wordsRead moreRead the paper on PubMedIFN-γ, TNF-α, IL-10, IL-17 and IL-22 secretion capacities and activation profile of T cells in psoriatic arthritis patients under disease-modifying antirheumatic drug therapy.Frontiers in immunology
Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritis.Lancet regional health. Americas
Prevalence of Psoriatic Arthritis among Patients with Psoriasis Using the Psoriatic Arthritis Screening Tool (PEST) Questionnaire in a Tertiary Government Institution.Acta medica Philippina
Does weather matter? Exploring associations between season and meteorological factors and psoriatic arthritis disease activity.RMD open
C reactive protein in psoriatic arthritis: an old biomarker or a jack of all trades?Rheumatology (Oxford, England)
Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic-Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double-Blind, Placebo-Controlled APEX Study.Arthritis & rheumatology (Hoboken, N.J.)
Single-cell analysis reveals CXCL16+ dendritic cells and clonally expanded GZMK+ CD4 T cells driving joint inflammation in psoriatic arthritis.Arthritis & rheumatology (Hoboken, N.J.)
Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials.Journal of psoriasis and psoriatic arthritis
Sex-specific outcomes in methotrexate therapy among patients with psoriatic arthritis and psoriasis.EULAR rheumatology open
Observational studyDiagnostic performance of FIB-4 in detecting advanced liver fibrosis in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis using methotrexate.Advances in rheumatology (London, England)
Sex of the Treating Rheumatologist and Disease Activity Outcomes in Psoriatic Arthritis.Mayo Clinic proceedings. Innovations, quality & outcomes
ReviewShort-term risk and long-term incidence rate of herpes zoster with upadacitinib in patients with atopic dermatitis and psoriatic arthritis: a systematic review and meta-analysis.Postepy dermatologii i alergologii
Observational studyChanges in biventricular myocardial function after six months of ixekizumab therapy in patients with psoriatic arthritis: a prospective speckle-tracking echocardiographic study.Rheumatology international
Depressive symptoms are associated with achieving remission in PsA patients - an analysis from the RABBIT-SpA register.BMC rheumatology
Cutaneous Deterioration Following Glucocorticoid Discontinuation in Psoriatic Arthritis: A Real-World Cohort Study.Journal of clinical medicine
IL-23 and monocyte interactions redirect human Th17.1 cells to an IL-17AhighIFN-γhigh potentially pathogenic profile.Frontiers in immunology
Case reportClinical case series: Emergence of psoriatic arthritis during biologic IL-23 pathway inhibition therapy for psoriasis.Frontiers in medicine
T cells form distinct spatially restricted immune responses in synovium of patients with psoriasis arthritis and rheumatoid arthritis.Frontiers in immunology
A Multi-Axis Plantar Load Measurement Platform for the Assessment of Foot Disorders: Comparison of Patients With Psoriatic Arthritis to a Healthy Control Cohort.Journal of foot and ankle research
Temporomandibular disorders in women with psoriatic arthritis by history of psoriasis: a cross-sectional study.Rheumatology international
Clinical and sonographic enthesitis in psoriatic arthritis patients and its relation to serum calprotectin level.Clinical rheumatology
TYK2-Wnt5a Crosstalk in Psoriatic Arthritis: A Hypothesized Immunopharmacological Axis for Inflammation and Structural Remodelling.Current drug targets
Beyond disease activity: patient-reported impact of disease states in psoriatic arthritis using PsAID-12 time-independent clustering.RMD open
Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies.Rheumatology (Oxford, England)
Distinct clinical profiles of methotrexate intolerance and hepatotoxicity in psoriatic arthritis.ARP rheumatology
ReviewFunctional characterization of genetic variants associated with response to tumor necrosis factor inhibitors in psoriatic arthritis patients.Autoimmunity reviews
ReviewFrom drug mechanism-based to driver-guided therapy: targeting disease drivers in psoriatic arthritis.EULAR rheumatology open
Effect of abatacept on bone in patients with psoriatic arthritis-results from a prospective interventional high-resolution imaging study (ABEPSA).EULAR rheumatology open
Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in patients with difficult-to-treat psoriatic arthritis? Results from a cross-sectional study.EULAR rheumatology open
Comparative enthesitis burden in psoriatic arthritis vs axial spondyloarthritis: a cross-sectional analysis of the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) registry.EULAR rheumatology open
Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study.Scandinavian journal of rheumatology
ReviewThe immunometabolic tipping point: forecasting the systemic shift from psoriasis to psoriatic arthritis.Frontiers in immunology
Clinic-Based Proportion of Psoriatic Arthritis and HLA-B27 Distribution in Korean Psoriasis Patients: A Retrospective Study.Annals of dermatology
Long-Term Safety and Efficacy of Upadacitinib in Patients with Psoriatic Arthritis: 5-Year Results from the Phase 3 SELECT-PsA 1 Study.Rheumatology and therapy
Cycling Versus Swapping After First-Line TNF Inhibitor Failure in Psoriatic Arthritis: Real-World Insights From the Argentine RECCAPSO Registry.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Ultrasound in psoriatic arthritis: from detecting abnormalities to defining clinical relevance.Rheumatology (Oxford, England)
Randomised trialEfficacy and safety of probiotic supplementation in PsA-a randomized controlled trial.Rheumatology (Oxford, England)
In plain wordsRead moreRead the paper on PubMedResponse to correspondence on 'Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study' by Luan et al.Annals of the rheumatic diseases
Comments on "Real-world effectiveness and safety of apremilast in psoriatic arthritis: results from the multicenter Italian MAPSI II study".Clinical rheumatology
Correction to "Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real-World Effectiveness and Safety From a Prospective Cohort".ACR open rheumatology
Why Is the Target Missed in Psoriatic Arthritis, and How Can We Disentangle the Underlying Drivers?The Journal of rheumatology
Performance of inflammatory back pain criteria in axial psoriatic arthritis compared with non-psoriatic axial spondyloarthritis and chronic low back pain: a cross-sectional study.Rheumatology international
Longitudinal fatigue outcomes and prediction in inflammatory arthritis: a real-world digital cohort study.Rheumatology international
Clinical, hematologic, and inflammatory factors associated with psoriatic arthritis in a Chinese hospital-based study.Frontiers in immunology
Characterising axial psoriatic arthritis in clinical practice: a retrospective analysis from the Rheumatic Diseases Portuguese Registry.Journal of rheumatic diseases
Predictors at diagnosis for initiation of biologic or targeted synthetic disease-modifying anti-rheumatic drugs in patients with spondyloarthritis and psoriatic arthritis.BMC rheumatology
A Case of Genital-Predominant Inverse Psoriasis With Psoriatic Arthritis Treated With Sequential IL-23/IL-17-Targeted Biologic Therapy.The Journal of dermatology
Real-World Strategies for Biologic Dose Escalation and Reduction in Psoriasis and Psoriatic Arthritis: A Systematic Review.Journal of cutaneous medicine and surgery
Immunological and Microbiological Findings in Psoriatic Arthritis, Psoriasis, and Periodontitis Individuals.Oral diseases
Psoriatic arthritis digital phenotyping and inflammation drivers (PDPID) study: protocol for an international multicentre prospective cohort.BMJ open
Causal Relationship Between Psoriatic Arthritis and Coronary Heart Disease: A Mendelian Randomization and Bioinformatics Analysis.Psoriasis (Auckland, N.Z.)
ReviewSex, Sex Hormones and Inflammatory Burden and Cardiovascular Risk in Patients with Spondyloarthritis.Biomolecules
ReviewCardiovascular Risk in Psoriatic Arthritis in the Treat-to-Target Era: A Focused Expert Narrative Review of Epidemiology, Risk Assessment, Vascular Imaging, and Prevention.Journal of clinical medicine